13F filer · CIK 1422848 ↗

Capital Research Global Investors

You are looking at Q1 2018. See the latest, Q2 2026 →

Reported value

$351.43B

+3.1% on the quarter before

Positions

443

37 new · 26 sold out

Top 10

25.8%

of the value

Est. gain

+$3.49B

on stocks held all quarter

Est. return

+1.1%

on those stocks since Q4 2017

Filed

May 15, 2018

On SEC EDGAR ↗

Positions as of Mar 31, 2018, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 43% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2017. Striped tiles are options.

Abbvie Inc5.2%
Netflix3.5%Amazon3.3%Microsoft2.6%
Amgen Inc2.3%
Verizon Communications Inc1.9%
Abbott Laboratories1.9%
Alphabet1.8%Intel1.7%Alphabet1.5%
Csx Corp1.4%
Unitedhealth Group Inc1.4%
Philip Morris International1.3%
Stryker Corp1.3%
Eog Resources Inc1.3%
Alibaba1.3%
General Dynamics Corp1.3%
Accenture Plc Cl A1.2%
Wells Fargo And Co1.2%
Broadcom1.2%
Thermo Fisher Scientific Inc1.1%
Twenty-First Century Fox Inc Cl A (Limited Voting)1.1%
Home Depot Inc1.0%
Altria Group Inc1.0%

Largest buys

Since Q4 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Broadcom~$4.05BNew · 0.0% → 1.2%+17,165,732 shares
  2. Lowes Companies Inc~$2.31BAdded · 0.0% → 0.7%+26,300,773 shares
  3. Booking Holdings Inc~$2.25BNew · 0.0% → 0.6%+1,082,432 shares
  4. Meta~$2.10BAdded · 0.1% → 0.7%+13,172,630 shares
  5. Abbott Laboratories~$1.68BAdded · 1.4% → 1.9%+27,958,563 shares
  6. Microsoft~$1.48BAdded · 2.1% → 2.6%+16,255,472 shares
  7. Qualcomm~$1.28BNew · 0.0% → 0.4%+23,076,309 shares
  8. Wells Fargo And Co~$1.24BAdded · 1.0% → 1.2%+23,667,056 shares
  9. Alphabet~$1.14BAdded · 1.5% → 1.8%+1,107,068 shares
  10. Altria Group Inc~$890.9MAdded · 0.9% → 1.0%+14,295,247 shares

Largest sells

Since Q4 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Broadcom Ltd~$6.25BSold out · 1.8% → 0.0%−24,332,311 shares
  2. Amazon~$2.62BCut · 3.4% → 3.3%−1,808,047 shares
  3. Priceline Group Inc (The)~$1.88BSold out · 0.6% → 0.0%−1,081,765 shares
  4. Apple~$1.72BCut · 0.9% → 0.4%−10,262,920 shares
  5. Prudential Financial Inc~$1.16BCut · 0.4% → 0.1%−11,181,437 shares
  6. Netflix~$1.05BCut · 2.5% → 3.5%−3,561,258 shares
  7. Micron~$868.4MCut · 0.4% → 0.3%−16,655,729 shares
  8. Texas Instruments~$796.0MCut · 1.3% → 1.0%−7,662,238 shares
  9. Verizon Communications Inc~$764.9MCut · 2.5% → 1.9%−15,995,091 shares
  10. Intel~$723.2MCut · 1.8% → 1.7%−13,886,396 shares

Holdings

As of Mar 31, 2018. Changes are in shares against Dec 31, 2017, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
Abbvie IncCOMMON STOCK · shares +0.04% · price −2.1%5.2%$18.28B−$397.6M
NetflixCOMMON STOCK · shares −7.9% · price +53.9%3.5%$12.23B+$4.28B
AmazonCOMMON STOCK · shares −18% · price +23.8%3.3%$11.77B+$2.26B
MicrosoftCOMMON STOCK · shares +19% · price +6.7%2.6%$9.18B+$483.4M
Amgen IncCOMMON STOCK · shares −7.6% · price −2.0%2.3%$8.02B−$160.9M
Verizon Communications IncCOMMON STOCK · shares −10% · price −9.7%1.9%$6.81B−$727.7M
Abbott LaboratoriesCOMMON STOCK · shares +33% · price +5.0%1.9%$6.78B+$242.7M
AlphabetCOMMON STOCK · shares +22% · price −1.4%1.8%$6.33B−$73.5M
IntelCOMMON STOCK · shares −11% · price +12.8%1.7%$6.07B+$690.0M
AlphabetCOMMON STOCK · shares +18% · price −1.5%1.5%$5.25B−$69.6M
Csx CorpCOMMON STOCK · shares −1.9% · price +1.3%1.4%$4.97B+$62.4M
Unitedhealth Group IncCOMMON STOCK · shares +12% · price −2.9%1.4%$4.82B−$130.4M
Philip Morris InternationalCOMMON STOCK · shares −9.0% · price −5.9%1.3%$4.74B−$298.2M
Stryker CorpCOMMON STOCK · shares −3.1% · price +3.9%1.3%$4.72B+$178.3M
Eog Resources IncCOMMON STOCK · shares −0.1% · price −2.4%1.3%$4.61B−$115.6M
AlibabaCOMMON STOCK · shares −8.1% · price +6.4%1.3%$4.50B+$272.3M
General Dynamics CorpCOMMON STOCK · shares +12% · price +8.6%1.3%$4.48B+$317.6M
Accenture Plc Cl ACOMMON STOCK · shares −0.09% · price +0.3%1.2%$4.20B+$11.2M
Wells Fargo And CoCOMMON STOCK · shares +44% · price −13.6%1.2%$4.08B−$447.9M
BroadcomCOMMON STOCK · shares New1.2%$4.05B—
Thermo Fisher Scientific IncCOMMON STOCK · shares −3.5% · price +8.7%1.1%$3.89B+$312.2M
Twenty-First Century Fox Inc Cl A (Limited Voting)COMMON STOCK · shares −4.3% · price +6.3%1.1%$3.80B+$224.0M
Home Depot IncCOMMON STOCK · shares +1.2% · price −6.0%1.0%$3.65B−$228.3M
Altria Group IncCOMMON STOCK · shares +33% · price −12.7%1.0%$3.59B−$393.8M
Nike Inc Cl BCOMMON STOCK · shares +17% · price +6.2%1.0%$3.55B+$177.3M
Total · 443 positions100%$351.43B+$3.49B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2017 to Q1 2018: 399 stocks held throughout, up $3.49B (+1.1%).

  1. Netflix+$4.28B+54%
  2. Amazon+$2.26B+24%
  3. Intel+$690.0M+13%
  4. Microsoft+$483.4M+7%
  5. Mastercard+$369.5M+16%
  6. Altria Group Inc−$393.8M−13%
  7. Abbvie Inc−$397.6M−2%
  8. Wells Fargo And Co−$447.9M−14%
  9. General Electric Co−$662.4M−23%
  10. Verizon Communications Inc−$727.7M−10%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$800.00B$400.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$716.87B+11%SEC ↗
Q1 2026$644.56B+19%SEC ↗
Q4 2025$541.73B+2%SEC ↗
Q3 2025$532.97B+7%SEC ↗
Q2 2025$499.46B+9%SEC ↗
Q1 2025$459.90B−5%SEC ↗
Q4 2024$486.38B+1%SEC ↗
Q3 2024$481.14B+6%SEC ↗
Q2 2024$455.74B+3%SEC ↗
Q1 2024$441.98B+9%SEC ↗
Q4 2023$406.47B+12%SEC ↗
Q3 2023$363.16B−3%SEC ↗
Q2 2023$373.18B+7%SEC ↗
Q1 2023$350.40B+6%SEC ↗
Q4 2022$330.88B+9%SEC ↗
Q3 2022$304.37B−5%SEC ↗
Q2 2022$321.05B−21%SEC ↗
Q1 2022$405.10B−11%SEC ↗
Q4 2021$452.67B+6%SEC ↗
Q3 2021$428.65B−0%SEC ↗
Q2 2021$429.52B+5%SEC ↗
Q1 2021$408.71B+6%SEC ↗
Q4 2020$385.30B+16%SEC ↗
Q3 2020$333.11B+5%SEC ↗
Q2 2020$316.13B+24%SEC ↗
Q1 2020$254.90B−24%SEC ↗
Q4 2019$333.48B+9%SEC ↗
Q3 2019$304.85B−3%SEC ↗
Q2 2019$314.99B−0%SEC ↗
Q1 2019$315.45B+10%SEC ↗
Q4 2018$287.02B−17%SEC ↗
Q3 2018$344.02B−6%SEC ↗
Q2 2018$366.12B+4%SEC ↗
Q1 2018$351.43B+3%SEC ↗
Q4 2017$340.76B+3%SEC ↗
Q3 2017$331.24B+4%SEC ↗
Q2 2017$319.49B+1%SEC ↗
Q1 2017$317.04B+3%SEC ↗
Q4 2016$308.47B+2%SEC ↗
Q3 2016$302.53B+3%SEC ↗
Q2 2016$292.47B+1%SEC ↗
Q1 2016$290.06BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.